Molecular and Behavioral Phenotypes Caused by Selective Disruption of M4 Muscarinic Acetylcholine Receptors in D1 Dopamine Receptor‐expressing Cells

Jongrye Jeon,Gitta Woertwein,Anders Fink-Jensen,David P. D. Woldbye,Christina Schulein,Guenther Schuetz,Albert A. Davis,Howard D. Rees,Allan I. Levey,Cuiling Li,Chuxia Deng,Yinghong Cui,Juergen Wess
DOI: https://doi.org/10.1096/fasebj.22.1_supplement.1127.9
2008-01-01
Abstract:The M4 muscarinic acetylcholine (ACh) receptor (M4 mAChR) is enriched in many regions of the forebrain including the striatum. Striatal M4 mAChRs are preferentially found on a subset of striatal projection neurons that express D1 dopamine receptors and give rise to the so‐called direct striato‐nigral pathway. To study the functional roles of these striatal M4 mAChRs, we used Cre/loxP technology to generate mutant mice that lack M4 mAChRs only in D1 receptor‐expressing neurons ('D1‐M4‐KO mice'). Adenylyl cyclase assays with striatal membranes showed that carbachol, a muscarinic agonist, was able to inhibit D1 receptor‐mediated increases in striatal cAMP levels in control mice, but lacked this activity in tissues from D1‐M4‐KO mice. In behavioral studies, D1‐M4‐KO mice showed a significant increase in basal locomotor activity, as compared to control littermates. Furthermore, apomorphine, a non‐selective dopamine receptor agonist, and SKF38393, a D1 receptor selective agonist, induced greater stimulatory locomotor responses in D1‐M4‐KO than in control mice. These studies provide novel insights into the functional roles of striatal M4 mAChRs and their potential involvement in the pathophysiology of various CNS disorders including Parkinson's disease and schizophrenia.
What problem does this paper attempt to address?